During clinical studies, the Virtual Cancer Patient Engine (VCP) was found to be 70 percent accurate in predicting individualized patient response to chemotherapy drugs. The significance of the ability of this new technology to make accurate predictions in cancer treatments that will work before treatment begins is a 40 to 45 percent better accuracy rate than is currently predicted by oncologists. VCP analyzes how chemotherapy drugs will affect the growth of the cancer, how the chemotherapy drugs will behave in the body and how the cancer cells will respond to the chemotherapy drugs using mathematical modeling and computerized simulation between biological, pathological and pharmacological processes of drug-patient interactions.According to researcher Dr. Abhik Mukherjee, "Every cancer is slightly different and every patient will respond to treatment differently. We wanted to find a way to predict how patients would respond to a particular drug in order to limit their side effects and give them the best chance of beating their disease."
Rather than throwing everything at the wall to see what sticks, as Katie Couric described current cancer treatments, this technology has the potential for creating individualized treatments specific to the patient and their cancer in determining what will work ahead of time without putting the patient through unnecessary treatments that will not work. To learn more, visit Optimata.


Last night I watched the first of the two-part series Breaking the Cancer Code with Katie Couric. Current chemotherapy and radiation treatments for cancer are, as Couric called it, "a scorched body approach" for cancer patients. "They throw everything against the wall to see what sticks."
Since the 1998 launch of National Colorectal Cancer Awareness Month, Olympus has been actively involved in
raising public awareness for colorectal cancer, and in fundraisers to support colorectal cancer research. Olympus
pioneered the development of colorectal cancer screening and treatment endoscopic technology that identifies and remove
polyps before they turn deadly. As a member of the National Colorectal Cancer Roundtable, Olympus has partnered with
public, private and voluntary colorectal cancer organizations each year in fundraising cancer campaigns.
In 1998, Katie Couric lost her husband, Jay Monahan, criminal defense attorney and television legal commentator, to
colon cancer. Monahan was 41 at the time of colon cancer diagnosis, and both Katie and Jay struggled to find treatment
options. After her husband's death eight months later, Couric wanted to create a clinic the two would have appreciated
during Monahan's battle with cancer. In 2004, The
In 1998, Katie Couric lost her husband,
Jay Monahan, in the prime of his life, to colon cancer. Since then, Couric has been a passionate crusader in raising
public awareness about colon cancer and in stressing the vital importance of colon cancer screening for everyone over
40 years of age. "Jay was just 41 when he was diagnosed, and it would have taken a very astute doctor to pick up
on it being colorectal cancer early on," says Couric. "He was pretty much asymptomatic. He had no family
history. You can be feeling perfectly fine – on top of the world physically – and still have colorectal
cancer. One of the many difficult things about this disease is you often have no symptoms. You may not have blood in
your stool, or have lost weight or your bowels habits may not have changed. But you could still have the disease."
In observance of National Colon Cancer Awareness Month, the Entertainment Industry Foundation's National
Colorectal Cancer Research Alliance, EIF's NCCRA, is offering 







